blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3509651

EP3509651 - USE OF RESECTED LIVER SERUM FOR WHOLE LIVER ENGINEERING [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.11.2023
Database last updated on 02.11.2024
FormerThe patent has been granted
Status updated on  25.11.2022
FormerGrant of patent is intended
Status updated on  14.07.2022
FormerExamination is in progress
Status updated on  25.12.2020
FormerRequest for examination was made
Status updated on  14.06.2019
FormerThe international publication has been made
Status updated on  23.03.2018
Formerunknown
Status updated on  27.09.2017
Most recent event   Tooltip24.05.2024Lapse of the patent in a contracting state
New state(s): IT		published on 26.06.2024  [2024/26]
Applicant(s)For all designated states
Miromatrix Medical Inc.
10399 West 70th Street
Eden Prairie, Minnesota 55344 / US
For all designated states
Mayo Foundation for Medical Education and Research
Mayo Medical Ventures
200 First Street SW
Rochester, Minnesota 55905 / US
[2022/32]
Former [2019/29]For all designated states
Miromatrix Medical Inc.
10399 West 70th Street
Eden Prairie, Minnesota 55344 / US
For all designated states
Mayo Foundation for Medical Education and Research
200 First Street S.E.
Rochester, MN 55905 / US
Inventor(s)01 / ROSS, Jeffrey
470 Liberty Heights Drive
Chaska, Minnesota 55318 / US
02 / YOUNG, Anne
18683 Bearpath Trail
Eden Prairie, Minnesota 55347 / US
03 / HAARSTAD, Allie
18683 Bearpath Trail
Eden Prairie, Minnesota 55347 / US
04 / NYBERG, Scott
200 First Street SW
Rochester, Minnesota 55905 / US
 [2019/29]
Representative(s)Uexküll & Stolberg
Partnerschaft von
Patent- und Rechtsanwälten mbB
Beselerstraße 4
22607 Hamburg / DE
[2019/29]
Application number, filing date17768594.806.09.2017
[2019/29]
WO2017US50278
Priority number, dateUS201662383772P06.09.2016         Original published format: US 201662383772 P
[2019/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018048899
Date:15.03.2018
Language:EN
[2018/11]
Type: A1 Application with search report 
No.:EP3509651
Date:17.07.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 15.03.2018 takes the place of the publication of the European patent application.
[2019/29]
Type: B1 Patent specification 
No.:EP3509651
Date:28.12.2022
Language:EN
[2022/52]
Search report(s)International search report - published on:EP15.03.2018
ClassificationIPC:A61L27/36, A61L27/38
[2019/29]
CPC:
A61L27/3616 (EP,US); A61L27/24 (US); A61L27/3604 (EP,US);
A61L27/3633 (EP,US); A61L27/3683 (US); A61L27/3804 (EP,US);
A61L27/3808 (EP,US); A61L27/3834 (EP,US); A61L27/3839 (US);
C12N5/0671 (US); A61L2430/28 (EP,US); C12N2500/84 (US);
C12N2533/90 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/29]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:VERWENDUNG VON RESEZIERTEM LEBERSERUM ZUM ENGINEERING DER GANZEN LEBER[2019/29]
English:USE OF RESECTED LIVER SERUM FOR WHOLE LIVER ENGINEERING[2019/29]
French:UTILISATION DE SÉRUM DE FOIE RÉSÉQUÉ POUR INGÉNIERIE DU FOIE ENTIER[2019/29]
Entry into regional phase07.03.2019National basic fee paid 
07.03.2019Designation fee(s) paid 
07.03.2019Examination fee paid 
Examination procedure07.03.2019Examination requested  [2019/29]
07.03.2019Date on which the examining division has become responsible
22.10.2019Amendment by applicant (claims and/or description)
13.01.2021Despatch of a communication from the examining division (Time limit: M06)
23.07.2021Reply to a communication from the examining division
15.07.2022Communication of intention to grant the patent
22.11.2022Fee for grant paid
22.11.2022Fee for publishing/printing paid
22.11.2022Receipt of the translation of the claim(s)
Opposition(s)29.09.2023No opposition filed within time limit [2023/49]
Fees paidRenewal fee
27.11.2019Renewal fee patent year 03
28.09.2020Renewal fee patent year 04
27.09.2021Renewal fee patent year 05
27.09.2022Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
30.09.201903   M06   Fee paid on   27.11.2019
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL28.12.2022
AT28.12.2022
CZ28.12.2022
DK28.12.2022
EE28.12.2022
ES28.12.2022
FI28.12.2022
HR28.12.2022
IT28.12.2022
LT28.12.2022
LV28.12.2022
PL28.12.2022
RO28.12.2022
RS28.12.2022
SI28.12.2022
SK28.12.2022
SM28.12.2022
NO28.03.2023
GR29.03.2023
IS28.04.2023
PT28.04.2023
[2024/26]
Former [2024/11]AL28.12.2022
AT28.12.2022
CZ28.12.2022
DK28.12.2022
EE28.12.2022
ES28.12.2022
FI28.12.2022
HR28.12.2022
LT28.12.2022
LV28.12.2022
PL28.12.2022
RO28.12.2022
RS28.12.2022
SI28.12.2022
SK28.12.2022
SM28.12.2022
NO28.03.2023
GR29.03.2023
IS28.04.2023
PT28.04.2023
Former [2023/46]AL28.12.2022
AT28.12.2022
CZ28.12.2022
DK28.12.2022
EE28.12.2022
ES28.12.2022
FI28.12.2022
HR28.12.2022
LT28.12.2022
LV28.12.2022
PL28.12.2022
RO28.12.2022
RS28.12.2022
SK28.12.2022
SM28.12.2022
NO28.03.2023
GR29.03.2023
IS28.04.2023
PT28.04.2023
Former [2023/39]AL28.12.2022
AT28.12.2022
CZ28.12.2022
EE28.12.2022
ES28.12.2022
FI28.12.2022
HR28.12.2022
LT28.12.2022
LV28.12.2022
PL28.12.2022
RO28.12.2022
RS28.12.2022
SK28.12.2022
SM28.12.2022
NO28.03.2023
GR29.03.2023
IS28.04.2023
PT28.04.2023
Former [2023/38]AL28.12.2022
AT28.12.2022
CZ28.12.2022
EE28.12.2022
ES28.12.2022
FI28.12.2022
HR28.12.2022
LT28.12.2022
LV28.12.2022
PL28.12.2022
RO28.12.2022
RS28.12.2022
SK28.12.2022
SM28.12.2022
NO28.03.2023
GR29.03.2023
PT28.04.2023
Former [2023/37]AL28.12.2022
AT28.12.2022
CZ28.12.2022
EE28.12.2022
ES28.12.2022
FI28.12.2022
HR28.12.2022
LT28.12.2022
LV28.12.2022
RO28.12.2022
RS28.12.2022
SM28.12.2022
NO28.03.2023
GR29.03.2023
PT28.04.2023
Former [2023/35]AT28.12.2022
CZ28.12.2022
EE28.12.2022
ES28.12.2022
FI28.12.2022
HR28.12.2022
LT28.12.2022
LV28.12.2022
RO28.12.2022
RS28.12.2022
SM28.12.2022
NO28.03.2023
GR29.03.2023
PT28.04.2023
Former [2023/34]EE28.12.2022
ES28.12.2022
FI28.12.2022
HR28.12.2022
LT28.12.2022
LV28.12.2022
RS28.12.2022
SM28.12.2022
NO28.03.2023
GR29.03.2023
PT28.04.2023
Former [2023/33]ES28.12.2022
FI28.12.2022
HR28.12.2022
LT28.12.2022
LV28.12.2022
RS28.12.2022
SM28.12.2022
NO28.03.2023
GR29.03.2023
Former [2023/25]FI28.12.2022
HR28.12.2022
LT28.12.2022
LV28.12.2022
RS28.12.2022
NO28.03.2023
GR29.03.2023
Former [2023/23]FI28.12.2022
LT28.12.2022
LV28.12.2022
NO28.03.2023
GR29.03.2023
Former [2023/22]FI28.12.2022
LT28.12.2022
NO28.03.2023
Former [2023/20]LT28.12.2022
NO28.03.2023
Cited inInternational search[Y]WO2010120539  (UNIV MINNESOTA [US], et al);
 [Y]WO2012005760  (MIROMATRIX MEDICAL INC [US], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.